May E - Search Results

1

Nonisotopic competitive RT-PCR assay to measure MDR1 gene expression.

Debuire B, Sol O, Lemoine A, May E. Debuire B, et al. Among authors: may e. Clin Chem. 1995 Jun;41(6 Pt 1):819-25. Clin Chem. 1995. PMID: 7539341

2

p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation.

Bourdon JC, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B. Bourdon JC, et al. Among authors: may e. Gastroenterology. 1995 Apr;108(4):1176-82. doi: 10.1016/0016-5085(95)90217-1. Gastroenterology. 1995. PMID: 7698586

3

Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas.

Debuire B, Paterlini P, Pontisso P, Basso G, May E. Debuire B, et al. Among authors: may e. Oncogene. 1993 Aug;8(8):2303-6. Oncogene. 1993. PMID: 8393166

4

Frequent microsatellite instability in post hepatitis B viral cirrhosis.

Salvucci M, Lemoine A, Azoulay D, Sebagh M, Bismuth H, Reyns M, May E, Debuire B. Salvucci M, et al. Among authors: may e. Oncogene. 1996 Dec 19;13(12):2681-5. Oncogene. 1996. PMID: 9000142

5

p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas.

Duthu A, Debuire B, Romano J, Ehrhart JC, Fiscella M, May E, Appella E, May P. Duthu A, et al. Among authors: may e, may p. Oncogene. 1992 Nov;7(11):2161-7. Oncogene. 1992. PMID: 1437144

6

Accumulation of an inactive form of p53 protein in cells treated with TNF alpha.

Drané P, Leblanc V, Miro-Mur F, Saffroy R, Debuire B, May E. Drané P, et al. Among authors: may e. Cell Death Differ. 2002 May;9(5):527-37. doi: 10.1038/sj.cdd.4400983. Cell Death Differ. 2002. PMID: 11973611

7

Further characterisation of the p53 responsive element--identification of new candidate genes for trans-activation by p53.

Bourdon JC, Deguin-Chambon V, Lelong JC, Dessen P, May P, Debuire B, May E. Bourdon JC, et al. Among authors: may e, may p. Oncogene. 1997 Jan 9;14(1):85-94. doi: 10.1038/sj.onc.1200804. Oncogene. 1997. PMID: 9010235

8

Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues.

Gotteland M, Desauty G, Delarue JC, Liu L, May E. Gotteland M, et al. Among authors: may e. Mol Cell Endocrinol. 1995 Jul;112(1):1-13. doi: 10.1016/0303-7207(95)03576-s. Mol Cell Endocrinol. 1995. PMID: 7589776

9

Human transforming growth factor alpha: sequence analysis of the 4.5-kb and 1.6-kb mRNA species.

Qian JF, Lazar-Wesley E, Breugnot C, May E. Qian JF, et al. Among authors: may e. Gene. 1993 Oct 15;132(2):291-6. doi: 10.1016/0378-1119(93)90210-t. Gene. 1993. PMID: 8224876

10

Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product?

Sancho-Garnier H, Delarue JC, Mouriesse H, Contesso G, May-Levin F, Gotteland M, May E. Sancho-Garnier H, et al. Among authors: may levin f, may e. Eur J Cancer. 1995 Oct;31A(11):1851-5. doi: 10.1016/0959-8049(95)00387-x. Eur J Cancer. 1995. PMID: 8541112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

858 results

Search Page

Filters